Variant report
Variant | rs3128437 |
---|---|
Chromosome Location | chr1:45729234-45729235 |
allele | C/T |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:7)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:7 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:45716599..45723837-chr1:45726714..45733883,8 | K562 | blood: | |
2 | chr1:45186275..45187906-chr1:45728961..45730546,2 | K562 | blood: | |
3 | chr1:45717171..45719961-chr1:45727838..45729738,2 | MCF-7 | breast: | |
4 | chr1:45722680..45725853-chr1:45727060..45729598,3 | K562 | blood: | |
5 | chr1:45728448..45730333-chr1:45735366..45738285,2 | MCF-7 | breast: | |
6 | chr1:45185994..45187906-chr1:45728961..45731095,3 | K562 | blood: | |
7 | chr1:45724453..45726184-chr1:45728358..45730973,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000199377 | Chromatin interaction |
rs_ID | r2[population] |
---|---|
rs11211075 | 0.86[YRI][hapmap];0.96[AMR][1000 genomes];0.92[EUR][1000 genomes] |
rs11211077 | 0.96[AMR][1000 genomes];0.92[EUR][1000 genomes] |
rs11211080 | 0.88[AMR][1000 genomes];0.89[EUR][1000 genomes] |
rs11211091 | 0.81[EUR][1000 genomes] |
rs1143726 | 0.96[YRI][hapmap];0.83[AFR][1000 genomes];0.96[AMR][1000 genomes];0.89[EUR][1000 genomes] |
rs1143727 | 0.85[AFR][1000 genomes];1.00[AMR][1000 genomes];0.92[EUR][1000 genomes] |
rs1144866 | 0.96[AMR][1000 genomes];0.92[EUR][1000 genomes] |
rs1144867 | 0.83[AFR][1000 genomes];1.00[AMR][1000 genomes];0.92[EUR][1000 genomes] |
rs1144870 | 0.96[YRI][hapmap];0.84[AFR][1000 genomes];1.00[AMR][1000 genomes];0.92[EUR][1000 genomes] |
rs1144871 | 0.96[YRI][hapmap];0.84[AFR][1000 genomes];1.00[AMR][1000 genomes];0.92[EUR][1000 genomes] |
rs1152017 | 0.96[AMR][1000 genomes];0.90[EUR][1000 genomes] |
rs1152018 | 0.96[AMR][1000 genomes];0.92[EUR][1000 genomes] |
rs1152020 | 0.84[AFR][1000 genomes];1.00[AMR][1000 genomes];0.92[EUR][1000 genomes] |
rs1152022 | 0.88[AFR][1000 genomes];0.88[AMR][1000 genomes];0.92[EUR][1000 genomes] |
rs11588448 | 0.92[EUR][1000 genomes] |
rs1226722 | 0.96[AMR][1000 genomes];0.92[EUR][1000 genomes] |
rs1226723 | 0.92[AMR][1000 genomes];0.92[EUR][1000 genomes] |
rs1226727 | 0.96[AMR][1000 genomes];0.92[EUR][1000 genomes] |
rs1226728 | 0.96[AMR][1000 genomes];0.89[EUR][1000 genomes] |
rs1226736 | 0.92[AMR][1000 genomes];0.97[EUR][1000 genomes] |
rs1226740 | 0.82[AFR][1000 genomes];1.00[AMR][1000 genomes];0.97[EUR][1000 genomes] |
rs1226749 | 0.92[YRI][hapmap];0.82[AFR][1000 genomes];1.00[AMR][1000 genomes];0.97[EUR][1000 genomes] |
rs1226911 | 0.88[AMR][1000 genomes] |
rs1226912 | 0.84[AFR][1000 genomes];1.00[AMR][1000 genomes];0.97[EUR][1000 genomes] |
rs12750360 | 0.87[AMR][1000 genomes];0.92[EUR][1000 genomes] |
rs16832411 | 0.89[YRI][hapmap];0.92[AMR][1000 genomes];0.92[EUR][1000 genomes] |
rs1698295 | 0.96[YRI][hapmap];0.82[AFR][1000 genomes];1.00[AMR][1000 genomes];0.97[EUR][1000 genomes] |
rs1938298 | 0.81[EUR][1000 genomes] |
rs1938302 | 1.00[YRI][hapmap];0.90[AFR][1000 genomes];1.00[AMR][1000 genomes];0.97[EUR][1000 genomes] |
rs1938406 | 0.82[AFR][1000 genomes];1.00[AMR][1000 genomes];0.97[EUR][1000 genomes] |
rs2096436 | 0.81[EUR][1000 genomes] |
rs2211644 | 0.89[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes] |
rs2356304 | 0.89[AFR][1000 genomes];1.00[AMR][1000 genomes];0.93[EUR][1000 genomes] |
rs2883902 | 0.82[AFR][1000 genomes];1.00[AMR][1000 genomes];0.97[EUR][1000 genomes] |
rs2997400 | 0.96[YRI][hapmap];0.82[AFR][1000 genomes];1.00[AMR][1000 genomes];0.97[EUR][1000 genomes] |
rs2997462 | 0.86[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes] |
rs3009973 | 0.96[YRI][hapmap];0.82[AFR][1000 genomes];1.00[AMR][1000 genomes];0.97[EUR][1000 genomes] |
rs3009976 | 0.85[AFR][1000 genomes];1.00[AMR][1000 genomes];0.97[EUR][1000 genomes] |
rs3009978 | 0.83[AFR][1000 genomes];1.00[AMR][1000 genomes];0.97[EUR][1000 genomes] |
rs3121731 | 0.96[YRI][hapmap];0.93[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes] |
rs3121768 | 0.81[EUR][1000 genomes] |
rs3121770 | 0.91[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes] |
rs3121771 | 0.81[EUR][1000 genomes] |
rs3128443 | 1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes] |
rs6429558 | 0.86[YRI][hapmap];0.96[AMR][1000 genomes];0.92[EUR][1000 genomes] |
rs6698681 | 0.81[AMR][1000 genomes];0.92[EUR][1000 genomes] |
rs6700502 | 0.88[EUR][1000 genomes] |
rs6702389 | 0.96[AMR][1000 genomes];0.92[EUR][1000 genomes] |
rs68139854 | 0.81[AMR][1000 genomes];0.92[EUR][1000 genomes] |
rs7517524 | 0.92[AMR][1000 genomes];0.89[EUR][1000 genomes] |
rs7528468 | 0.81[AMR][1000 genomes];0.89[EUR][1000 genomes] |
rs7548075 | 0.96[AMR][1000 genomes];0.92[EUR][1000 genomes] |
rs7552211 | 0.81[AMR][1000 genomes];0.89[EUR][1000 genomes] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | nsv529677 | chr1:45179509-45748571 | Weak transcription Enhancers ZNF genes & repeats Strong transcription Flanking Active TSS Active TSS Genic enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 424 gene(s) | inside rSNPs | diseases |
2 | nsv1002026 | chr1:45187594-45758048 | Flanking Active TSS Enhancers Genic enhancers Strong transcription Weak transcription Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 386 gene(s) | inside rSNPs | diseases |
3 | nsv498036 | chr1:45428030-46050934 | Active TSS Enhancers Flanking Active TSS Genic enhancers Weak transcription Strong transcription Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 191 gene(s) | inside rSNPs | diseases |
4 | nsv998187 | chr1:45677251-45732377 | ZNF genes & repeats Enhancers Flanking Active TSS Weak transcription Active TSS Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNA | 13 gene(s) | inside rSNPs | diseases |
5 | nsv1014509 | chr1:45687523-45887501 | Flanking Active TSS Active TSS Enhancers Weak transcription Genic enhancers Strong transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 57 gene(s) | inside rSNPs | diseases |
No data |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:45726200-45731600 | Weak transcription | Skeletal Muscle Female | skeletal muscle |
2 | chr1:45727000-45731200 | Weak transcription | HepG2 | liver |
3 | chr1:45728000-45731600 | Weak transcription | NHLF | lung |
4 | chr1:45728200-45731800 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
5 | chr1:45728200-45731800 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |
6 | chr1:45729200-45729400 | Enhancers | K562 | blood |
7 | chr1:45729200-45731000 | Weak transcription | HUVEC | blood vessel |